Matteo Zurlo - Search Results

Year	Number of Results
2019	1
2020	1
2021	3
2022	8
2023	12
2024	2

1

The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p.

Papi C, Gasparello J, Zurlo M, Cosenza LC, Gambari R, Finotti A. Papi C, et al. Among authors: zurlo m. Noncoding RNA. 2023 Apr 18;9(2):29. doi: 10.3390/ncrna9020029. Noncoding RNA. 2023. PMID: 37104011 Free PMC article.

2

Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4⁺ and CD8⁺ T cells.

Zurlo M, Nicoli F, Proietto D, Dallan B, Zuccato C, Cosenza LC, Gasparello J, Papi C, d'Aversa E, Borgatti M, Scapoli C, Finotti A, Gambari R. Zurlo M, et al. J Cell Mol Med. 2023 Feb;27(3):353-364. doi: 10.1111/jcmm.17655. Epub 2023 Jan 10. J Cell Mol Med. 2023. PMID: 36625233 Free PMC article. Clinical Trial.

3

The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies.

Gambari R, Zuccato C, Cosenza LC, Zurlo M, Gasparello J, Finotti A, Gamberini MR, Prosdocimi M. Gambari R, et al. Among authors: zurlo m. Biology (Basel). 2023 Sep 2;12(9):1202. doi: 10.3390/biology12091202. Biology (Basel). 2023. PMID: 37759601 Free PMC article. Review.

4

Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management.

Traeger-Synodinos J, Vrettou C, Sofocleous C, Zurlo M, Finotti A, Gambari R; International Hemoglobinopathy Research Network (INHERENT). Traeger-Synodinos J, et al. Among authors: zurlo m. Int J Mol Sci. 2024 Mar 17;25(6):3400. doi: 10.3390/ijms25063400. Int J Mol Sci. 2024. PMID: 38542374 Free PMC article. Review.

5

Cationic Calix[4]arene Vectors to Efficiently Deliver AntimiRNA Peptide Nucleic Acids (PNAs) and miRNA Mimics.

Gasparello J, Papi C, Zurlo M, Volpi S, Gambari R, Corradini R, Casnati A, Sansone F, Finotti A. Gasparello J, et al. Among authors: zurlo m. Pharmaceutics. 2023 Aug 10;15(8):2121. doi: 10.3390/pharmaceutics15082121. Pharmaceutics. 2023. PMID: 37631335 Free PMC article.

6

Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β⁰39-Globin Gene Editing and Induction of Fetal Hemoglobin.

Cosenza LC, Zuccato C, Zurlo M, Gambari R, Finotti A. Cosenza LC, et al. Among authors: zurlo m. Genes (Basel). 2022 Sep 26;13(10):1727. doi: 10.3390/genes13101727. Genes (Basel). 2022. PMID: 36292612 Free PMC article.

7

Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3',4',5'-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold.

Romagnoli R, Prencipe F, Oliva P, Cacciari B, Balzarini J, Liekens S, Hamel E, Brancale A, Ferla S, Manfredini S, Zurlo M, Finotti A, Gambari R. Romagnoli R, et al. Among authors: zurlo m. Molecules. 2020 Apr 7;25(7):1690. doi: 10.3390/molecules25071690. Molecules. 2020. PMID: 32272719 Free PMC article.

8

The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells.

Zurlo M, Gasparello J, Verona M, Papi C, Cosenza LC, Finotti A, Marzaro G, Gambari R. Zurlo M, et al. Exp Cell Res. 2023 Dec 15;433(2):113853. doi: 10.1016/j.yexcr.2023.113853. Epub 2023 Nov 7. Exp Cell Res. 2023. PMID: 37944576 Free article.

9

Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy.

Zurlo M, Gasparello J, Cosenza LC, Breveglieri G, Papi C, Zuccato C, Gambari R, Finotti A. Zurlo M, et al. Genes (Basel). 2023 Feb 23;14(3):556. doi: 10.3390/genes14030556. Genes (Basel). 2023. PMID: 36980829 Free PMC article.

10

Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β⁰39-thalassemia patients.

Cosenza LC, Gasparello J, Romanini N, Zurlo M, Zuccato C, Gambari R, Finotti A. Cosenza LC, et al. Among authors: zurlo m. Mol Ther Methods Clin Dev. 2021 Apr 3;21:507-523. doi: 10.1016/j.omtm.2021.03.025. eCollection 2021 Jun 11. Mol Ther Methods Clin Dev. 2021. PMID: 33997100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year